LSD could be approved for anxiety in the US in 2027

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: New Scientist
LSD could be approved for anxiety in the US in 2027WorldPing
Image via New Scientist.

What happened

The psychedelic drug LSD eased anxiety in a late-stage trial, paving the way for a probable approval in the US within the next two years…

Key facts

  • Reported by New Scientist and published Tue, 15 Sep 2026 12:00:00 UTC.

Why it matters

Research findings and mission results set the evidence base that policy, funding and later discoveries build on.

What to watch next

  • Peer review status and replication of the findings
  • Mission milestones and next scheduled attempt
  • Funding or policy decisions that follow

Coverage timeline

When each newsroom published on this story, oldest first — all times UTC.

  1. Room-temperature skyrmion-based synapses could pave the way for energy-efficient AI

  2. UK could 'unlock' 100 more oil and gas projects, say North Sea bosses

  3. Could the clues to ancient alien civilizations be hiding in moon dust?

  4. 'That could push them over the edge': How climate change could fuel impulsive behavior

  5. LSD could be approved for anxiety in the US in 2027

  6. One in three uni students experience serious financial hardship. Could concession cards for all help?

  7. Data centre could threaten rare species, says charity

Sources

The original report was published by New Scientist. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at New Scientist

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage